diabetes management

By Laura Lovett February 8, 2018
Remote patient monitoring combined with a special diet that cuts starchy carbs is helping some patients reverse their Type 2 diabetes, according to a recent study published in Diabetes Therapy. The investigation, complied by Virta Health, found that 94 percent of patients who were on insulin, using the Virta mobile tool, and altering their diet decreased or eliminated their insulin dosage by the...
By Jonah Comstock January 11, 2018
Correction: A previous version of this story mistated the projected timeline for the combined product. It is Q1 this year, not Q1 next year. WellDoc and Voluntis, two companies with FDA-cleared, clinically validated platforms aimed at the management of Type 2 diabetes, have signed a commercial agreement to combine their technologies and offer joint products in the future. “My thought is that a...
By Jonah Comstock July 25, 2017
Senseonics and TypeZero's R&D partnership around the artificial pancreas is leveling up. The two organizations announced today that they would team up with pharmaceutical and medical device company Roche to launch three European clinical trials of their combined closed-loop system. The research is backed by the National Institutes of Health (NIH) through its International Diabetes Closed Loop...
By Jonah Comstock June 29, 2017
While it may or may not be working on a secret glucose wearable, Apple has definitely upgraded its HealthKit app framework to provide more tracking options for people with diabetes. In addition, the company made some other upgrades to both the HealthKit and ResearchKit frameworks. Apple engineers shared these updates at WWDC earlier this month. “Our users love using Apple products to help manage...
By Jonah Comstock May 1, 2017
AmalgamRx, a newly unstealthed company founded by WellDoc founders Ryan Sysko and Dr. Suzanne Clough, has received FDA clearance for iSage, an insulin titration algorithm. “One of the big challenges with insulin is that it’s scary for patients, they don’t necessarily want to go on it,” Sysko told MobiHealthNews. “So we wanted to find a way to help them optimize their insulin regimen and get to...
By Jonah Comstock April 3, 2017
Use of the One Drop Mobile platform from New York City-based One Drop led to a one point reduction in A1C, according to data from a retrospective study released by the company last week. They also shared preliminary data from a study of One Drop Expert, a mobile tool that adds 24-7 access to a certified diabetes educator.  "People want to know if health apps work," Dr. Chandra Osborn, vice...
By Jonah Comstock March 16, 2017
Technology-enabled diabetes management company Livongo Health has raised $52.5 million in new funding in a round co-led by General Catalyst, an existing investor, and international investment company Kinnevik. Other investors included Microsoft Ventures, American Investment Holdings, and EDBI, a Singapore-based fund whose portfolio includes WellTok, GoBalto, and Sotera Wireless. All previous...
By Heather Mack February 17, 2017
In a head-to-head comparison of sensor-augmented insulin pumps, the touchscreen device from Tandem Diabetes Care outperformed that from Medtronic, according to new data presented at the Annual Advanced Technologies and Treatments for Diabetes conference in Paris. The self-reported data from San Diego-based Tandem comes from a retrospective study analyzing de-identified data from 3,046 Tandem SAP...
By Jonah Comstock February 16, 2017
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche. The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
By Heather Mack January 30, 2017
Milpitas, California-based Bigfoot Biomedical, a diabetes management company working on their first product, announced an investment from the Juvenile Diabetes Research Foundation (JDRF)’s newly launched venture fund, T1D, focused on early stage companies working on type 1 diabetes. The terms of the investment were not disclosed, but Bigfoot previously raised $35.5 million. The funding will be...